Description
Long-acting HIV prevention option – one injection every 6 months after initiation phase
Overview
Lenacapavir is a long-acting injectable HIV prevention medicine designed for individuals at substantial risk of HIV infection.
It reduces reliance on daily tablets by offering protection through a single injection every 6 months after a short initiation phase.
How It Works
Initiation Phase
- Day 1: First injection + oral tablets
- Day 2: Additional oral tablets to complete initiation
Maintenance Phase
- Every 6 months: Single injection for ongoing protection
Key Benefits
- 6-month long protection per injection
- Reduces need for daily medication adherence
- Discreet HIV prevention option
- Supports individuals with adherence challenges
- Improves continuity of HIV prevention coverage
Who Can Use It
Lenacapavir may be suitable for individuals who:
- Are at ongoing risk of HIV infection
- Struggle with daily oral PrEP adherence
- Prefer long-acting prevention methods
- Require discreet prevention options
Clinical assessment is required before initiation.
Get Started via Zivoko
Connect with a healthcare provider to assess eligibility and begin structured prevention support.
Frequently Asked Questions
How often is Lenacapavir taken?
After the initial oral and injection phase, it is taken as a single injection every 6 months.
Do I still need tablets?
Yes. Tablets are used only during the initiation phase (Day 1–2). After that, only injections are required.
Is it better than daily PrEP?
It is not “better” for everyone. It is an alternative designed for people who struggle with daily adherence or prefer long-acting protection.
Can I self-administer the injection?
No. It must be administered by a trained healthcare professional.
Reviews
There are no reviews yet.